جستجوی استاد راهنمای دانشگاهی

• Cardiovascular System Modelling
• Biosignal Processing
• Wearable Nanosensors
• +۵ مورد دیگر

Haipeng Liu is an Assistant Professor in the Centre for Intelligent Healthcare at Coventry University. His research focuses on cardiovascular system modeling, biosignal processing, wearable nanosensors, and AI-driven diagnostics. He has supervised over 100 research outputs and holds editorial roles in journals like Frontiers in Physiology and Electronics . His work bridges clinical needs with technological innovation, particularly in healthcare technology and cardiovascular diagnostics. Research Interests: Computational modeling of cardiovascular systems, AI-enhanced diagnostics, wearable sensors, and medical imaging. Key Awards: British Heart Foundation Travel Award (2019), First Prize in National Mathematics Competition (2011). Collaborations: Active in global research networks, including the World Stroke Organization. His recent work emphasizes machine learning applications in cardiology and stroke diagnostics, with publications in Physics of Fluids , European Journal of Radiology , and Frontiers in Genetics . He is a sought-after advisor for PhD students exploring healthcare technology.

• Neurocritical Care
• Vascular Neurology
• Traumatic Brain Injury
• +۶ مورد دیگر

Dr. Gunjan Y. Parikh serves as an Associate Professor in the Department of Neurology at the University of Maryland School of Medicine, where she also functions as the Medical Director of the UMMC Neuro Critical Care Unit. Her clinical practice focuses on the intersection of neurology and critical care medicine, with particular expertise in managing patients with acute neurological emergencies including traumatic brain injury, intracerebral hemorrhage, and subarachnoid hemorrhage. Dr. Parikh completed her undergraduate education with a BA in Biochemistry from The University of Texas at Austin, followed by her MD from Texas A&M College of Medicine. Her clinical training includes an Internal Medicine internship at St. Vincent's Hospital - Manhattan, Neurology residency at Barrow Neurological Institute at Saint Joseph's Hospital and Medical Center (where she also served as Chief Resident), and specialized fellowship training in Neurocritical Care/Vascular Neurology at Columbia University Medical Center/Weill Cornell Medical Center. She further enhanced her research skills through an NINDS Research Fellowship in Neuroimaging at the National Institutes of Health. Her research program centers on identifying biomarkers during the resuscitation phase of patients with acute brain injuries that determine lesion repair, restoration of function, and recovery of consciousness. This work has led to significant contributions in characterizing the MRI signature of primary microvascular injury after head trauma and other acute brain injuries through both in vivo and ex vivo investigations. Her lab integrates multimodality monitoring with advanced neuroimaging techniques to translate findings to clinical care and develop outcome measures for clinical trials targeting currently untreatable aspects of brain injury such as demyelination and neurodegeneration. Analysis of Dr. Parikh's recent publications reveals a strong focus on translational neuroscience with emphasis on neuroimaging techniques, biomarker discovery, and clinical applications for acute brain injury management. Her work spans from basic science investigations of microvascular injury to clinical studies on patient outcomes, with particular attention to traumatic brain injury, intracerebral hemorrhage, and subarachnoid hemorrhage. Recent publications demonstrate increasing integration of data science approaches for predicting neurological deterioration and developing automated clinical assessment tools. Fellow of the Neurocritical Care Society (2024) Member, American Academy of Neurology Member, Neurocritical Care Society Member, National Neurotrauma Society Dr. Parikh serves as Site Co-PI for the DISCOVERY study (Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on Recovery) under NINDS/NIA U19 NS115388, and as SubK site-PI for the REACH-ICH study (Race/Ethnicity, Hypertension and Prevention of VCID and Stroke after Intracerebral Hemorrhage) under NINDS/NIH 5R01NS093870-08. Her research has been featured in multiple media outlets including MD Edge Psychiatry, News Medical, and SciTech Daily, highlighting her contributions to understanding vascular injury in traumatic brain injury. As Medical Director of the UMMC Neuro Critical Care Unit, Dr. Parikh leads a multidisciplinary team focused on providing high-reliability, quality care with emphasis on patient experience. Her research group actively investigates cerebral hemodynamics, neuroimaging biomarkers, and clinical decision support tools for patients with acute neurological conditions, with particular attention to improving triage and interhospital transfer of neuroscience patients.

• Vascular Biology
• Renal Physiology
• Hypertension Pathophysiology
• +۳ مورد دیگر

Jonathan Nelson is an Assistant Professor in the Division of Nephrology & Hypertension at the University of Southern California (USC) Keck School of Medicine. He holds a PhD in Molecular and Medical Genetics from Oregon Health & Science University (OHSU), where he also completed clinical training in Anesthesiology, Cardiovascular Medicine, and Nephrology. His research focuses on vascular biology and the renin-angiotensin system's role in kidney microvasculature regulation, with funding from the NIH, American Heart Association, and Collins Medical Trust. Education: Bachelor’s degree in Biochemistry, University of Washington PhD in Molecular and Medical Genetics, Oregon Health & Science University Research interests include understanding how angiotensin II signaling impacts kidney and cardiovascular health, particularly in hypertension and microvascular dysfunction. His work bridges molecular mechanisms with clinical implications, leveraging mouse models to study renal physiology and disease pathways. Publications highlight his focus on renal transporters, endothelial signaling, and angiotensin system dynamics. Recent work explores ACE2 filtration in kidneys and COP9 signalosome roles in renal injury. Grants & Funding: NIH, American Heart Association, Collins Medical Trust. Labs/Teams: His research is conducted within the USC Keck School of Medicine’s Division of Nephrology & Hypertension, collaborating with cardiovascular and renal biology experts.

• Cardiovascular Epidemiology
• Sex and Gender Differences in Cardiovascular Disease
• Comparative Effectiveness Research
• +۵ مورد دیگر

Louise Pilote, MD, MPH, PhD is Professor of Medicine in the Department of Medicine, Division of Internal Medicine , McGill University , and Senior Scientist in the Cardiovascular Health Across the Lifespan Program at the Research Institute of the McGill University Health Centre (RI-MUHC) , Montréal, Canada. Education: Louise Pilote holds the combined degrees of MD, MPH, and PhD, reflecting advanced clinical, public-health and research training that underpins her translational work. Research Focus: Internationally recognized pioneer in sex- and gender-based cardiovascular epidemiology , developing novel gender indices to disentangle biological (sex) and sociocultural (gender) determinants of cardiovascular outcomes. Leads the multinational GOING-FWD consortium (Gender Outcomes International Group to Further Well-being Development), integrating sex/gender analytics across 30 cohorts totaling 30 million patients with chronic diseases. Authority on comparative effectiveness and pharmacoepidemiology leveraging administrative “Big Data”, clinical registries, and advanced biostatistical/machine-learning methodologies. Current clinical-translational projects include imaging-based diagnosis of coronary microvascular dysfunction , a condition disproportionately affecting women. Scientific Impact & Awards: While formal awards are not enumerated in the supplied text, Dr Pilote’s sustained leadership as senior author on major Canadian and international cardiovascular guidelines, her role in founding the GOING-FWD network, and her extensive publication record (398 PubMed-indexed articles, 1988-2025) collectively constitute significant peer recognition. Students & Mentoring: Specific trainee names are not provided in the text; however, as Professor at McGill and Senior Scientist at RI-MUHC she supervises graduate students, clinical research fellows, and post-doctoral researchers in cardiovascular epidemiology, data science, and gender medicine. Laboratories & Teams: Dr Pilote heads the cardiovascular epidemiology research group within the Centre for Outcomes Research and Evaluation (CORE) at RI-MUHC, coordinating a multi-disciplinary team of biostatisticians, data scientists, clinician-scientists, and trainees.

Lacy Alexanderمشاهده پروفایل

استاد

• Microvascular Function
• Human Cutaneous Circulation
• Cardiovascular Disease
• +۴ مورد دیگر

Lacy Alexander is a Professor of Kinesiology and Research Professor in Charge at The Pennsylvania State University’s Department of Kinesiology, within the College of Health and Human Development. Her research focuses on microvascular dysfunction mechanisms in diseases like hypertension and aging, using the cutaneous circulation as a model. She holds a Ph.D. (2007) and M.S. (2002) in Kinesiology/Human Physiology from Penn State and University of Oregon. Her work investigates nitric oxide signaling, inflammatory pathways, and pharmacological interventions (e.g., aspirin) in vascular health. Key research areas include thermal regulation, endometriosis-related cardiovascular risks, and preeclampsia aftermaths. She leads NIH-funded projects and has published over 129 peer-reviewed articles. Notable studies address heat stress mitigation in vulnerable populations, estrogen’s role in endothelial function, and holistic endometriosis care. Affiliations include the Center for Healthy Aging and Integrative and Biomedical Physiology. She co-edits the Journal of Applied Physiology and actively promotes gender equity in science. Her grants total over $5 million, emphasizing translational research in vascular biology and clinical applications.

Bülent DEMİRمشاهده پروفایل

استاد

• Cardiovascular Medicine
• Coronary Artery Disease
• Metabolic Syndrome
• +۳ مورد دیگر

Prof. Dr. Bülent DEMİR serves as Head of the Department of Cardiology at Istanbul Medipol University International Faculty of Medicine since 2010. His clinical career spans multiple prestigious institutions including Ankara High Specialization Training Hospital, Bakırköy Dr. Sadi Konuk Hospital, and Turkish Hospital in Doha-Qatar. Fluent in English, he maintains active clinical practice at Bagcilar Medipol Mega University Hospital. His research focuses on inflammatory mechanisms in cardiovascular disease , particularly examining biomarkers like IL-17A, zonulin, and epicardial adipose tissue in conditions including metabolic syndrome, coronary artery disease, and cardiac syndrome X. Recent work explores connections between endocrine disorders (thyroid dysfunction, gestational diabetes) and cardiovascular outcomes. Analysis of his 15 most recent publications reveals strong emphasis on multimarker approaches to understanding vascular inflammation, with significant contributions to identifying novel angiographic phenomena like contrast layering clearance. His work bridges basic vascular biology (endothelial cell cultures, statin effects) with clinical cardiology applications. Prof. DEMİR actively supervises research with frequent collaborations across cardiology, endocrinology, and nephrology domains. His team has presented findings at major international forums including ESC Congress and Turkish Cardiology Congresses, though specific grant funding details are not documented in available materials.

Alejandro R. Chadeمشاهده پروفایل

استاد

• Cardiovascular Physiology
• Renal Disease Mechanisms
• Microcirculatory Function
• +۳ مورد دیگر

Alejandro R. Chade, MD, is a Professor of Medical Pharmacology and Physiology at the University of Missouri School of Medicine and a NextGen Precision Health Investigator. His research focuses on cardiovascular and renal physiologic imaging, microcirculatory function, and mechanisms of renal and cardiac disease. Dr. Chade’s laboratory develops translational swine models of chronic kidney disease (CKD) and hypertension, leveraging advanced imaging techniques such as multi-detector CT and echocardiography to study renal and cardiac function. His work also explores novel therapeutic strategies targeting the renal and cardiac microcirculation to mitigate inflammation and improve organ function. Education: MD from Universidad Nacional de Cuyo (1996), Cardiology Residency and Fellowship at Hospital Lagomaggiore (2001), and postdoctoral training at the Mayo Clinic (2005). He has held roles at the University of Mississippi Medical Center before joining the University of Missouri. Research Interests include mechanisms linking CKD to cardiovascular disease, imaging-based diagnostics, and drug delivery systems for targeted therapies. His lab investigates macrophage polarization, NF-kB signaling pathways, and the role of mitochondrial DNA in renal injury. Key Awards: American Heart Association Established Investigator Award, Mid-Career Award, and numerous travel and recognition awards for hypertension and renal research. Publications focus on swine models, renal-cardiac crosstalk, and VEGF-based therapies, with high-impact contributions to American Journal of Physiology and Hypertension . Labs/Teams: Leads the NextGen Precision Health Initiative, collaborating on translational research to bridge basic science and clinical applications.

Marinko Sarunicمشاهده پروفایل

استاد مدعو

• Biomedical Imaging
• Optical Coherence Tomography
• Microscopy
• +۲ مورد دیگر

Marinko Sarunic is an Adjunct Professor at the School of Engineering Science , Simon Fraser University . He holds a PhD in Biomedical Engineering from Duke University and has been recognized as a Michael Smith Foundation for Health Research Scholar . His research focuses on biomedical imaging , particularly optical coherence tomography (OCT) , microscopy , and low-coherence interferometry , with applications in diabetic retinopathy , Alzheimer’s disease , and age-related macular degeneration . Dr. Sarunic's work spans adaptive optics , deep learning , and sensorless OCT systems , emphasizing clinical translation and open-source software development (e.g., OCTAVA ). His Google Scholar publications highlight multimodal imaging , vascular heterogeneity analysis , and AI-driven diagnostics for retinal diseases. His contributions include the Michael Smith Foundation for Health Research Scholar award. Though not currently teaching courses, his collaborations and leadership in retinal imaging and medical device innovation are pivotal for advancing non-invasive diagnostics in neurodegenerative and diabetic conditions .

• Cardiovascular Medicine
• Coronary Artery Disease
• Fractional Flow Reserve
• +۶ مورد دیگر

Dr. Keith Oldroyd is an Honorary Professor at the University of Glasgow's School of Cardiovascular & Metabolic Health. His research focuses on coronary physiology, myocardial infarction, and interventional cardiology, with a particular emphasis on fractional flow reserve (FFR) and coronary microvascular dysfunction. He leads major clinical trials such as CorMicA and FAMOUS-NSTEMI, assessing diagnostic and therapeutic strategies in coronary artery disease. Key contributions include advancing understanding of coronary microvascular dysfunction, optimizing PCI outcomes, and evaluating the clinical impact of influenza vaccination post-MI. Collaborations with institutions globally highlight interdisciplinary work in drug-eluting stents, biomaterials, and cardiovascular imaging. Over 150 peer-reviewed publications (2001–2024) Principal Investigator for CorMicA trial Leadership in Glasgow PRAMI and EVOLVE 48 studies Labs/Teams: Active in translational cardiology research at the Golden Jubilee National Hospital and University of Glasgow's cardiovascular imaging and intervention teams.

• Cardio-Oncology
• Air Pollution and Cardiovascular Disease
• Space Medicine
• +۵ مورد دیگر

Kazuaki Negishi is a Professor of Medicine and Head of the Discipline of Medicine at Sydney Medical School Nepean, University of Sydney's Faculty of Medicine and Health. He holds adjunct professorships at the University of Tasmania and is a board-certified cardiologist in Japan and Australia. His expertise spans cardio-oncology, air pollution-cardiovascular links, space medicine, and advanced imaging. Clinically, he practices at Nepean Hospital and previously led the Echo lab at Royal Hobart Hospital. He completed his MD and PhD in Japan, with additional training at Cleveland Clinic, USA. Research interests include cardiovascular imaging, subclinical myocardial insults, and health policy. He leads a team of 1 Senior Research Fellow, 2 Post-Doctoral fellows, and supervises PhD students across multiple institutions. Awards include the National Heart Foundation Future Leader Fellowship and international society recognitions (FACC, FESC, FAHA). Key collaborations include NASA, Gunma University (Japan), and the ANZACT Network. His work on SUCCOUR trials and REDUCE trial (sonothrombolysis) aims to improve cardiovascular outcomes in oncology patients. He chairs editorial boards for JACC: Cardiovascular Imaging and Journal of the American Society of Echocardiography .

Joyce Gonzalesمشاهده پروفایل

استاد

• Pulmonary Medicine
• Critical Care Medicine
• Hematology
• +۲ مورد دیگر

Dr. Joyce Gonzales is a Professor in the Department of Medicine (Pulmonary Division) at the Medical College of Georgia. She holds an MD from the University of Health Sciences (2002) and a BSN from Excelsior College (1998), with certifications in ACLS instruction (2007), Georgia state physician licensure (2009), and American Board of Internal Medicine (2006). Her research focuses on pulmonary and vascular pathophysiology, including bacterial toxin mechanisms in lung injury, endothelial barrier regulation in sickle cell disease, and novel anticoagulant therapies. Key areas include: Molecular pathways of pneumolysin-induced endothelial damage Thrombin-PAR signaling in vascular permeability Pulmonary complications of hematological disorders Therapeutic interventions for acute chest syndrome She has received multiple honors for service excellence: William Beaumont Army Medical Center Humanitarian Award (2003) Department of the Army Commander’s Award for Civilian Service (1999) Department of the Army Service Recognition (1996) Larimer County Health Department Service Award (1993) Dr. Gonzales teaches core medical courses including RMED 5000 (Medicine), GMED 5034 (Medical Critical Care), and RPUL 5000 (Pulmonary & Critical Care).

Travis W. Heinمشاهده پروفایل

استاد

• Medical Physiology
• Vascular Biology
• Diabetes Research
• +۳ مورد دیگر

Travis W. Hein, PhD, is a Professor in the Department of Medical Physiology at Texas A&M University's School of Medicine. His research focuses on microvascular dysfunction in diabetes, particularly in retinal and coronary microvessels, and its implications for vision loss and heart failure. He also investigates spaceflight-associated neuro-ocular syndrome (SANS) mechanisms in astronauts. Hein holds significant teaching awards, including the 2023 R. Kelly Hester Distinguished Teaching Award and membership in the Academy of Distinguished Medical Educators. Education: BA in Biology from St. Olaf College (1992), PhD in Medical Physiology from Texas A&M Health Science Center (1997). Research interests emphasize molecular mechanisms of vasomotor regulation, diabetes-induced vascular damage, and space health challenges. His work identifies therapeutic targets for microvascular diseases and explores ocular blood flow dynamics in space environments. Key publications highlight breakthroughs in retinal degeneration therapies (e.g., stanniocalcin-1), diabetic microvascular complications, and cardiovascular dysfunction mechanisms. His articles span 20+ years, demonstrating sustained contributions to vascular biology and translational medicine. Scientific awards: 2023 R. Kelly Hester Distinguished Teaching Award 2021 Elected to Academy of Distinguished Medical Educators 2017 Texas A&M Distinguished Teaching Award Grants and mentoring: Extensive NIH-funded research programs and training of graduate students/postdocs in cardiovascular and ocular physiology. Collaborates on space health initiatives through NASA partnerships. Labs/Teams: Directs Texas A&M's Microvascular Physiology Lab, focusing on translational research in diabetes and space health. Active in multidisciplinary teams addressing ocular vascular dysfunction and cardiac microcirculation.

• Neurovascular Function
• Ischemic Brain Injury
• Neurodegenerative Diseases
• +۳ مورد دیگر

Costantino Iadecola, M.D., is a leading neuroscientist and neurologist at Weill Cornell Medicine, serving as Director and Chair of the Feil Family Brain and Mind Research Institute and holding the Anne Parrish Titzell Professor of Neurology. His work bridges neurovascular biology, ischemic injury mechanisms, and neurodegenerative disease pathogenesis, with over 390 peer-reviewed publications. Neurovascular Unit Neurodegenerative Disease Mechanisms Stroke-Induced Inflammation Microbiome-Brain Interactions Dr. Iadecola has pioneered understanding of neurovascular dysfunction in Alzheimer's disease and demonstrated the role of innate immunity in ischemic brain injury. His research employs advanced models to study hypertension, dietary influences (e.g., salt), and vascular oxidative stress in cognitive impairment. Recent work focuses on: Cerebral Amyloid Angiopathy (2025) Hypertension-Induced Cognitive Decline (2025) Systemic Determinants of Brain Aging (2024) ApoE4-Linked Vascular Dysfunction (2024) Scientific accolades include: McHenry Award (AAN) Jacob Javits Awards (NIH) Willis Award (AHA) Zenith Fellow (Alzheimer’s Association) Clarivate Highly Cited Researcher He serves on editorial boards for Circulation Research , Stroke , Journal of Neuroscience , and Annals of Neurology , and holds leadership roles in major research organizations. His work has been featured in Nature Neuroscience (2023) and informs clinical guidelines through American Heart Association scientific statements.

• Endothelial Cell Biology
• Angiogenesis
• Vascular Biology
• +۷ مورد دیگر

Jean-Philippe Gratton is a Full Professor and Director of the Department of Pharmacology and Physiology at the Université de Montréal's Faculty of Medicine. He heads the Endothelial Cell Biology Unit at the Montreal Clinical Research Institute (IRCM), a position he has held since 2002. His dual appointments reflect his significant contributions to both academic medicine and clinical research in vascular biology. Dr. Gratton earned his Bachelor's degree in Biochemistry (1992), followed by a Master's (1995) and Doctorate (1998) in Pharmacology, all from the University of Sherbrooke. He completed his post-doctoral training at Yale University School of Medicine in 2002, establishing the foundation for his career in vascular biology research. His research focuses on endothelial cell biology, particularly the cellular mechanisms controlling endothelial cell proliferation, survival, and differentiation. Using molecular and cellular biology techniques combined with modern pharmacology, Dr. Gratton investigates intracellular signaling of endothelial growth factors, especially VEGF receptor dynamics and their influence on nitric oxide release. His work spans cardiovascular diseases and tumor angiogenesis, with particular interest in plasma membrane lipid microdomains, eNOS regulation, and endothelial dysfunction. His laboratory's findings have significant implications for understanding both vascular health and cancer progression. Analysis of his recent publications reveals a consistent research trajectory centered on endothelial cell signaling mechanisms, with increasing focus on the intersection between vascular biology and cancer immunology. His work demonstrates how endothelial signaling pathways influence tumor microenvironments and can be targeted to improve cancer therapies, particularly through modulation of AXL receptor signaling and angiogenic processes. Université de Montréal Research Chair in Endothelial Cell Signaling and Angiogenesis (2013-present) Merck Canada Chair in Pharmacology at the University of Montreal Dr. Gratton leads a productive research program with consistent funding and numerous collaborations across institutions. His laboratory serves as a training ground for the next generation of vascular biologists and pharmacologists, contributing significantly to understanding endothelial cell function in health and disease. The Endothelial Cell Biology Unit at IRCM maintains state-of-the-art facilities for molecular and cellular analysis of vascular processes.

C. Michael Gibsonمشاهده پروفایل

استاد پژوهش

• Interventional Cardiology
• Cardiovascular Research
• Clinical Trials
• +۳ مورد دیگر

C. Michael Gibson, MD is a leading interventional cardiologist, cardiovascular researcher, and educator at Harvard Medical School , where he serves as the Chief Executive Officer of the Baim Institute and PERFUSE Research Institute . These institutes have led over 1,000 studies and 5,500 peer-reviewed publications, including 144 in the New England Journal of Medicine . Key Roles: Director of Coronary Care Unit, Cardiac Catheterization Laboratory Director, Chief of Cardiology, Vice Chairman of Medicine Education: BS, MS, and MD from the University of Chicago (Phi Beta Kappa, AOA), followed by training at Brigham and Women’s Hospital and Beth Israel Deaconess Medical Center Research Focus: Pioneered the open artery and microvasculature hypothesis in heart attacks, developed widely used coronary blood flow measures (TIMI frame count, TIMI myocardial perfusion grade), and leads virtual clinical trials like the HEARTLINE trial of the Apple Watch. Current work includes Factor XI inhibitors (milvexian) and apolipoprotein AI infusions for cardiovascular disease. Scientific Contributions: Over 148,000 citations, 659 publications, and leadership in guidelines like the Bleeding Academic Research Consortium . Notable trials include ANDexanet Alfa for anticoagulant reversal and the PEERLESS study comparing mechanical thrombectomy to thrombolysis in pulmonary embolism. Leadership: FDA Cardiorenal Panel member (2017–2021), founder of WikiDoc.org and ClinicalTrialsResults.org Media Influence: Chief Medical Correspondent for the American College of Cardiology, 435K+ social media followers Scientific Awards: Consistently ranked among the world’s most highly cited authors (Thomson Reuters, 2014–present), 50 Most Influential Voices in Healthcare (Medika Life, 2021), and Boston’s Top Doctors (multiple years).